메뉴 건너뛰기




Volumn 48, Issue 1, 2013, Pages 1-7

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium

Author keywords

colistimethate sodium; colistin; cystic fibrosis; pharmacodynamics; pharmacokinetics; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; AZLOCILLIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; CO TRIMAZOLE; COLISTIMETHATE; COLISTIN; IMIPENEM; MEROPENEM; NY 14814; PIPERACILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

EID: 84872841018     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22664     Document Type: Article
Times cited : (15)

References (28)
  • 2
    • 0029934215 scopus 로고    scopus 로고
    • Management of pulmonary disease in patients with cystic fibrosis
    • Ramsey BW,. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996; 335: 179-188.
    • (1996) N Engl J Med , vol.335 , pp. 179-188
    • Ramsey, B.W.1
  • 3
    • 33744454666 scopus 로고    scopus 로고
    • Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
    • Bergen PJ, Jian Li, Rayner CR, Nation RL,. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006; 50: 1953-1958.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 1953-1958
    • Bergen, P.J.1    Jian, L.2    Rayner, C.R.3    Nation, R.L.4
  • 6
    • 84872835202 scopus 로고    scopus 로고
    • Coly-Mycin M Parenteral, P.I. Parkedale Pharmaceuticals, Inc.
    • Coly-Mycin M Parenteral, P.I. Parkedale Pharmaceuticals, Inc. 2006.
    • (2006)
  • 7
    • 84872860349 scopus 로고    scopus 로고
    • Colomycin Injection P.I. Forest Laboratories UK, Limited 2010
    • Colomycin Injection P.I. Forest Laboratories UK, Limited. 2010.
  • 12
    • 0011970183 scopus 로고    scopus 로고
    • Antimicrobial agents: Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents
    • Limbird JGHaLE, editor. New York: McGraw-Hill
    • Chambers HF,. Antimicrobial agents: Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents. In:, Limbird JGHaLE, editor. Goodman and Gilman's The pharmacological basis of therapeutics. New York: McGraw-Hill; 2001. pp 1239-1272.
    • (2001) Goodman and Gilman's the Pharmacological Basis of Therapeutics , pp. 1239-1272
    • Chambers, H.F.1
  • 13
    • 0035013931 scopus 로고    scopus 로고
    • The pharmacokinetics of colistin in patients with cystic fibrosis
    • Reed MD, Stern RC, O'Riordan MA, Blumer JL,. The pharmacokinetics of colistin in patients with cystic fibrosis. J Clin Pharmacol 2001; 41: 645-654.
    • (2001) J Clin Pharmacol , vol.41 , pp. 645-654
    • Reed, M.D.1    Stern, R.C.2    O'Riordan, M.A.3    Blumer, J.L.4
  • 16
    • 40049095690 scopus 로고    scopus 로고
    • Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: Studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
    • Bergen PJ, Li J, Nation RL, Turnidge JD, Coulthard K, Milne RW,. Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. J Antimicrob Chemother 2008; 61: 636-642.
    • (2008) J Antimicrob Chemother , vol.61 , pp. 636-642
    • Bergen, P.J.1    Li, J.2    Nation, R.L.3    Turnidge, J.D.4    Coulthard, K.5    Milne, R.W.6
  • 17
    • 0035118424 scopus 로고    scopus 로고
    • In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    • Li J, Turnidge J, Milne R, Nation RL, Coulthard K,. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 2001; 45: 781-785.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 781-785
    • Li, J.1    Turnidge, J.2    Milne, R.3    Nation, R.L.4    Coulthard, K.5
  • 18
    • 0030783691 scopus 로고    scopus 로고
    • Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis
    • Conway SP, Pond MN, Watson A, Etherington C, Robey HL, Goldman MH,. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis. Thorax 1997; 52: 987-993.
    • (1997) Thorax , vol.52 , pp. 987-993
    • Conway, S.P.1    Pond, M.N.2    Watson, A.3    Etherington, C.4    Robey, H.L.5    Goldman, M.H.6
  • 19
    • 0033761572 scopus 로고    scopus 로고
    • Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis
    • Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M,. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis. Ann Pharmacother 2000; 34: 1238-1242.
    • (2000) Ann Pharmacother , vol.34 , pp. 1238-1242
    • Conway, S.P.1    Etherington, C.2    Munday, J.3    Goldman, M.H.4    Strong, J.J.5    Wootton, M.6
  • 20
    • 84860195528 scopus 로고    scopus 로고
    • In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in pseudomonas aeruginosa biofilm infection
    • Hengzhuang W, Hengzhuang W, Wu H, Ciofu O, Song Z, Høiby N,. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in pseudomonas aeruginosa biofilm infection. Antimicrob Agents Chemother 2012; 56: 2683-2690.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 2683-2690
    • Hengzhuang, W.1    Hengzhuang, W.2    Wu, H.3    Ciofu, O.4    Song, Z.5    Høiby, N.6
  • 22
    • 77956119797 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model
    • Bergen PJ, Bulitta JB, Forrest A, Tsuji BT, Li J, Nation RL,. Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model. Antimicrob Agents Chemother 2010; 54: 3783-3789.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 3783-3789
    • Bergen, P.J.1    Bulitta, J.B.2    Forrest, A.3    Tsuji, B.T.4    Li, J.5    Nation, R.L.6
  • 23
    • 77149178390 scopus 로고    scopus 로고
    • Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models
    • Dudhani RV, Turnidge JD, Coulthard K, Milne RW, Rayner CR, Li J, Nation RL,. Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. Antimicrob Agents Chemother 2010; 54: 1117-1124.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 1117-1124
    • Dudhani, R.V.1    Turnidge, J.D.2    Coulthard, K.3    Milne, R.W.4    Rayner, C.R.5    Li, J.6    Nation, R.L.7
  • 24
    • 79959248672 scopus 로고    scopus 로고
    • Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients
    • Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, Silveira FP, Forrest A, Nation RL,. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 2011; 55: 3284-3294.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 3284-3294
    • Garonzik, S.M.1    Li, J.2    Thamlikitkul, V.3    Paterson, D.L.4    Shoham, S.5    Jacob, J.6    Silveira, F.P.7    Forrest, A.8    Nation, R.L.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.